A team of researchers led by University of Ottawa professor Alain Stinzi has received $1,971,800 from the Canadian Institutes of Health Research and its partners in support of research that could have a significant impact on people living with inflammatory bowel disease (IBD).
Inflammatory bowel disease inflames the lining of the gastrointestinal tract and disrupts the body’s ability to digest food, absorb nutrition and eliminate waste in a healthy manner.
The researchers will assess the contribution of diet in IBD development and the persistent inflammation that defines the condition. By examining the impact of diet on intestinal bacteria, their work will shed light on the complex interactions among diet, gut microbiota and host, and provide important information on the personalized dietary and microbiota changes needed to keep people with IBD healthy.
Nearly 250,000 Canadians are affected by IBD, the main forms being Crohn’s disease and ulcerative colitis. Most alarming, the number of Canadian children with IBD has doubled since 1995.
Research funding is part of an investment of $16 million made by the Canadian government through the Canadian Institutes of Health Research, in partnership with Genome BC and Crohn’s and Colitis Canada.
Research team members are from the Children’s Hospital of Eastern Ontario, the University of Guelph, the University of British Columbia and BC Children’s Hospital.
Media Relations Officer